Shu‐Yun Ma

799 total citations
45 papers, 456 citations indexed

About

Shu‐Yun Ma is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Shu‐Yun Ma has authored 45 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Shu‐Yun Ma's work include Lymphoma Diagnosis and Treatment (14 papers), T-cell and Retrovirus Studies (4 papers) and MicroRNA in disease regulation (4 papers). Shu‐Yun Ma is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), T-cell and Retrovirus Studies (4 papers) and MicroRNA in disease regulation (4 papers). Shu‐Yun Ma collaborates with scholars based in China, United States and Singapore. Shu‐Yun Ma's co-authors include Qingqing Cai, Jun Cai, Yang� Yang, Xiao‐Peng Tian, Yuchen Zhang, Panpan Liu, Yi Xia, Qingqing Zhang, Zi Liu and Ning Su and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shu‐Yun Ma

41 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Yun Ma China 14 198 156 117 106 75 45 456
Huangming Hong China 10 212 1.1× 237 1.5× 191 1.6× 165 1.6× 97 1.3× 51 554
Jia-Bin Lu China 9 222 1.1× 371 2.4× 98 0.8× 122 1.2× 163 2.2× 10 610
Shina Horiuchi Japan 9 345 1.7× 191 1.2× 129 1.1× 150 1.4× 40 0.5× 11 562
Vasilios Papavasiliou Canada 12 195 1.0× 180 1.2× 43 0.4× 57 0.5× 76 1.0× 14 422
Radek Jakša Czechia 10 138 0.7× 146 0.9× 93 0.8× 47 0.4× 45 0.6× 27 326
Timothy A. Yap United Kingdom 8 289 1.5× 200 1.3× 72 0.6× 111 1.0× 40 0.5× 10 568
Katherine A. Rybinski United States 9 190 1.0× 192 1.2× 32 0.3× 62 0.6× 71 0.9× 23 464
Xianfu Sun China 13 279 1.4× 219 1.4× 61 0.5× 262 2.5× 44 0.6× 42 586
Ted Shih United States 6 201 1.0× 222 1.4× 50 0.4× 92 0.9× 47 0.6× 9 524
Amir Aledavood Iran 11 248 1.3× 121 0.8× 62 0.5× 139 1.3× 40 0.5× 19 530

Countries citing papers authored by Shu‐Yun Ma

Since Specialization
Citations

This map shows the geographic impact of Shu‐Yun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Yun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Yun Ma more than expected).

Fields of papers citing papers by Shu‐Yun Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Yun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Yun Ma. The network helps show where Shu‐Yun Ma may publish in the future.

Co-authorship network of co-authors of Shu‐Yun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Yun Ma. A scholar is included among the top collaborators of Shu‐Yun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Yun Ma. Shu‐Yun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Shu‐Yun, Jiahui Wang, Qian Zhong, et al.. (2025). Single-cell and spatial transcriptomics reveal intratumor heterogeneity and immune evasion in natural killer/T cell lymphoma. iScience. 28(10). 113626–113626.
3.
4.
Li, Wenyun, et al.. (2024). Preparation and characterization of moringin-loaded chitosan-coated liposomes and their antibacterial activity against Staphylococcus aureus. International Journal of Biological Macromolecules. 282. 136815–136815. 3 indexed citations
6.
Su, Ning, Fang Yu, Shu‐Yun Ma, et al.. (2022). Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma. Frontiers in Immunology. 13. 835103–835103. 13 indexed citations
7.
Zhao, Yuhang, et al.. (2022). O-GlcNAc transferase promotes the nuclear localization of the focal adhesion–associated protein Zyxin to regulate UV-induced cell death. Journal of Biological Chemistry. 298(4). 101776–101776. 8 indexed citations
8.
Yu, Fang, Ning Su, Shu‐Yun Ma, et al.. (2022). Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis. Annals of Hematology. 101(3). 595–605. 3 indexed citations
9.
Cai, Jun, Xiao‐Peng Tian, Shu‐Yun Ma, et al.. (2021). A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study. British Journal of Cancer. 125(3). 402–412. 11 indexed citations
10.
Yu, Fang, Shu‐Yun Ma, Ning Su, et al.. (2021). Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma. Leukemia Research. 111. 106705–106705. 6 indexed citations
11.
Chen, Xing, et al.. (2021). MiR-133a delivery to osteoblasts ameliorates mechanical unloading-triggered osteopenia progression in vitro and in vivo. International Immunopharmacology. 97. 107613–107613. 7 indexed citations
12.
Ma, Shu‐Yun, Xiao‐Peng Tian, Jun Cai, et al.. (2021). A prognostic immune risk score for diffuse large B‐cell lymphoma. British Journal of Haematology. 194(1). 111–119. 12 indexed citations
13.
Tian, Xiao‐Peng, Jun Cai, Shu‐Yun Ma, et al.. (2020). BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma. Cancer Communications. 40(6). 245–259. 19 indexed citations
14.
Su, Ning, Xuanye Zhang, Shu‐Yun Ma, et al.. (2020). Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases. Head & Neck. 42(8). 1970–1980. 15 indexed citations
16.
Ma, Shu‐Yun, et al.. (2018). The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer. Biomedicine & Pharmacotherapy. 108. 1686–1693. 49 indexed citations
17.
Chen, Rui, Yurong Zhang, Li Wang, et al.. (2018). MicroRNA-21 attenuates oxygen and glucose deprivation induced apoptotic death in human neural stem cells with inhibition of JNK and p38 MAPK signaling. Neuroscience Letters. 690. 11–16. 15 indexed citations
18.
Chen, Rui, Yanmei Liu, Qian Su, et al.. (2017). Hypoxia stimulates proliferation of rat neural stem/progenitor cells by regulating mir-21: an in vitro study. Neuroscience Letters. 661. 71–76. 11 indexed citations
20.
Ma, Shu‐Yun. (1993). The Exit, Voice, and Struggle to Return of Chinese Political Exiles. Pacific Affairs. 66(3). 368–368. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026